+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pigmentation Disorders Treatment Market by Indication, Treatment & Therapies, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 180 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4968687
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pigmentation Disorders Treatment Market grew from USD 6.78 billion in 2023 to USD 7.28 billion in 2024. It is expected to continue growing at a CAGR of 7.42%, reaching USD 11.21 billion by 2030.

Pigmentation disorders treatment encompasses a range of therapies aimed at addressing conditions that cause alterations in skin color, such as hyperpigmentation, melasma, and vitiligo. The scope of this market is driven by a growing awareness of skin health, rising demand for aesthetic treatments, and an increase in disposable income which allows consumers to invest in skincare solutions. The necessity for effective treatment options is underscored by the psychological impact pigmentation disorders can have on individuals, emphasizing the need for accessible, efficient, and safe therapies. Applications span across dermatological clinics, cosmetic centers, and hospitals, with end-users including patients seeking improvements in skin tone consistency and reduction of visible blemishes. Market growth is influenced by technological advancements in lasers and light therapy, increased R&D focusing on non-invasive procedures, and a surge in product launches featuring advanced ingredients like retinoids and peptides.

Opportunities arise particularly in emerging markets, where growing middle-class populations are fueling demand for cosmetic treatments. Teledermatology and home-use light therapy devices present new potential for market expansion, catering to consumers seeking convenience and privacy. However, challenges such as high treatment costs, risk of side effects, and regulatory hurdles pose limitations to market growth. Additionally, there is a constant need for healthcare providers to stay updated with rapidly evolving treatment protocols.

For innovation and research, businesses could focus on developing customizable treatment regimens tailored to individual genetic and environmental factors, as well as exploring natural and bio-based treatment options to cater to the rising popularity of clean and sustainable products. The market's dynamic nature demands a keen understanding of consumer preferences and regulatory landscapes. Investment in collaborations with technology firms and research institutions for advanced treatment models can provide competitive advantages, making these areas ripe for business growth.

Understanding Market Dynamics in the Pigmentation Disorders Treatment Market

The Pigmentation Disorders Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Rising awareness and concerns about importance of skincare
    • Growing expenditure on cosmetics and skincare products
    • Rising R&D spending and aggressive marketing strategies
  • Market Restraints
    • High cost of treatments and varying output results
  • Market Opportunities
    • Technological advancements like laser treatment and needling process
    • Advancements in various drugs like azelaic acid
  • Market Challenges
    • Increasing skin sensitivity, allergies and reactions to some

Exploring Porter’s Five Forces for the Pigmentation Disorders Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Pigmentation Disorders Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Pigmentation Disorders Treatment Market

External macro-environmental factors deeply influence the performance of the Pigmentation Disorders Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Pigmentation Disorders Treatment Market

The Pigmentation Disorders Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Pigmentation Disorders Treatment Market

The Pigmentation Disorders Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Pigmentation Disorders Treatment Market

The Pigmentation Disorders Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pigmentation Disorders Treatment Market, highlighting leading vendors and their innovative profiles. These include Affiliated Dermatology, Allergan, Inc., Derma Med Spa, EpiPharm AG, GK Dermatology, PC, Kaya Limited, La Roche-Posay by L’Oréal Singapore Pte. Ltd., Obagi Cosmeceuticals LLC, Skin Deep Laser Services, VIVIER PHARMA USA, and Water's Edge Dermatology.

Market Segmentation & Coverage

This research report categorizes the Pigmentation Disorders Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Indication
    • Hyperpigmentation
    • Hypopigmentation
  • Treatment & Therapies
    • Chemical Peels
    • Dermabrasion
    • Laser Resurfacing
    • Melasma
  • End User
    • Dermatology Clinics
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising awareness and concerns about importance of skincare
5.1.1.2. Growing expenditure on cosmetics and skincare products
5.1.1.3. Rising R&D spending and aggressive marketing strategies
5.1.2. Restraints
5.1.2.1. High cost of treatments and varying output results
5.1.3. Opportunities
5.1.3.1. Technological advancements like laser treatment and needling process
5.1.3.2. Advancements in various drugs like azelaic acid
5.1.4. Challenges
5.1.4.1. Increasing skin sensitivity, allergies and reactions to some
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Pigmentation Disorders Treatment Market, by Indication
6.1. Introduction
6.2. Hyperpigmentation
6.3. Hypopigmentation
7. Pigmentation Disorders Treatment Market, by Treatment & Therapies
7.1. Introduction
7.2. Chemical Peels
7.3. Dermabrasion
7.4. Laser Resurfacing
7.5. Melasma
8. Pigmentation Disorders Treatment Market, by End User
8.1. Introduction
8.2. Dermatology Clinics
8.3. Hospitals
9. Americas Pigmentation Disorders Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pigmentation Disorders Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Pigmentation Disorders Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. PIGMENTATION DISORDERS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. PIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. PIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. PIGMENTATION DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PIGMENTATION DISORDERS TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYPERPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYPOPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMABRASION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER RESURFACING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 22. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 29. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 30. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 32. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 33. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 42. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 47. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 50. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 56. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 74. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 84. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 87. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 90. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 93. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 96. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 102. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 110. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 111. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 114. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 116. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 117. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 128. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 129. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 137. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 138. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. PIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 146. PIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Pigmentation Disorders Treatment Market, which are profiled in this report, include:
  • Affiliated Dermatology
  • Allergan, Inc.
  • Derma Med Spa
  • EpiPharm AG
  • GK Dermatology, PC
  • Kaya Limited
  • La Roche-Posay by L’Oréal Singapore Pte. Ltd.
  • Obagi Cosmeceuticals LLC
  • Skin Deep Laser Services
  • VIVIER PHARMA USA
  • Water's Edge Dermatology

Methodology

Loading
LOADING...

Table Information